Dr. Rahul Kushwah reports

PREDICTMEDIX AI AND KGK SCIENCE PARTNER TO ENHANCE HEALTH RESEARCH AND PRODUCT DEVELOPMENT

Predictmedix AI Inc. has formed a significant partnership with KGK Science, a respected name in clinical research and regulatory consulting aimed at advancing the frontiers of health research and product development. This collaboration leverages Predictmedix AI's cutting-edge health assessment technologies with KGK Science's deep expertise in clinical research and regulatory matters, aiming to bring about transformative changes in health care innovation.

The partnership introduces a new operational vertical for Predictmedix, with the potential to significantly enhance the efficiency of clinical trials and yield considerable returns on investment. By incorporating Predictmedix's innovative technologies into KGK Science's clinical trials, the initiative is expected to redefine participant screening and health data collection accuracy, and introduce new methods in continuous monitoring.

Targeting key improvements in clinical trial efficiency, health product development and market positioning, this strategic alliance represents a concerted effort to tap into unexplored potential, streamline research processes and establish both companies as leaders in advanced health assessment technologies.

Dr. Rahul Kushwah, chief operating officer of Predictmedix, commented on the collaboration's strategic importance, stating: "Our partnership with KGK Science is a testament to our shared vision for leveraging advanced health assessment technologies to open new avenues in health research and product development. We are committed to this collaboration as a means to innovate and improve upon the standards of health assessments."

The partnership is poised to have a broad impact, not only in enhancing clinical trial methodologies and outcomes but also in setting new standards for health product innovation. By bringing together Predictmedix's technological capabilities and KGK Science's research and regulatory prowess, this collaboration is set to offer meaningful advancements in health care solutions.

In summary, the alliance between Predictmedix AI and KGK Science is structured around a shared goal of enhancing health research and product development through innovative technologies and expertise. This collaboration marks a significant step toward improving health outcomes and operational efficiencies, underscoring a mutual commitment to excellence and innovation in the health care sector.

About Predictmedix AI Inc.

Predictmedix AI is an emerging provider of rapid health screening and remote patient care solutions globally. The company's Safe Entry Stations -- powered by a proprietary artificial intelligence (AI) -- use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including 19 physiological vital parameters, impairment by drugs or alcohol, fatigue, or various mental illnesses. Predictmedix AI's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes.

We seek Safe Harbor.